Volume 10, Number 8—August 2004
Research
Group G Streptococcal Bacteremia in Jerusalem
Ronit Cohen-Poradosu*, Joseph Jaffe*, David Lavi*, Sigal Grisariu-Greenzaid*, Ran Nir-Paz*, Lea Valinsky†, Mary Dan-Goor†, Colin Block*, Bernard Beall‡, and Allon E. Moses*
Table 1
Summary of clinical characteristic of 94 patients with group G streptococcal bacteremia
| Characteristic | No. of patients (%) |
|---|---|
| Age (y) |
|
| <10 |
3 (3.1) |
| 10–50 |
28 (29.8) |
| 51–75 |
42 (44.7) |
| >75 |
21 (22.3) |
| Median (range) |
62 (2–92) |
| Male |
51 (54.2) |
| Median LOHa in days |
10 |
| Underlying disorder |
|
| Diabetes mellitus |
33 (35.1) |
| Malignancy |
33 (35.1) |
| Hypertension |
18 (19.1) |
| No disease |
8 (8.5) |
| Type of infection |
|
| Cellulitis |
56 (59.6) |
| Primary bacteremia |
18 (19.1) |
| Soft-tissue infectionb |
4 (4.3) |
| Bone and joint |
4 (4.3) |
| Endocarditis |
3 (3.1) |
| Respiratory |
3 (3.1) |
| Postpartum |
1 (1.1) |
| Line sepsis |
1 (1.1) |
| Unknown |
4 (4.3) |
| Death rate | 5 (5.3) |
aLOH, length of hospitalization.
bSoft tissue infection, pressure sore attributable to diabetes
Page created: March 01, 2011
Page updated: March 01, 2011
Page reviewed: March 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.